Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
The article says what the drugs are in the second paragraph…
No, it’s not amphetamines.
I was joking in the beginning part there. But if you knew what they were why didn’t you say what they were? Now if you excuse me I need to order some tapeworms off of the dark web.